Your session is about to expire
← Back to Search
JYNNEOS Vaccine for Monkeypox
Study Summary
This trial will compare two vaccine regimens to the standard in adults and adolescents to see which one is better.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2014 Phase 3 trial • 4005 Patients • NCT01144637Trial Design
Find a Location
Logistics
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Media Library
- I can read and agree to follow the study's procedures and attend all visits.I have HIV, on ART for 6+ months, CD4 count >350, no AIDS illness last year.You have a heart condition that makes participating in the study risky, such as a history of inflammation of the heart or a structural heart defect.I have received a smallpox vaccine.My chronic conditions have been stable and haven't required hospitalization or major treatment changes in the last month.I have not received and do not plan to receive any vaccines within a week of the study vaccination.You have had a serious reaction or anaphylaxis in the past after receiving a vaccine.I haven't had and won't get a live vaccine around the time of my trial participation.I am between 12 and 50 years old.I haven't taken more than 20 mg/day of prednisone or its equivalent for 2 weeks in the last month.Your immune system is weak, as decided by the doctor in charge.I have been vaccinated against smallpox or monkeypox.I haven't taken any immunosuppressing drugs in the last 4 weeks.You have taken a new or experimental drug or vaccine within the past 3 months.
- Group 1: 5
- Group 2: 4
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 13 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor open to elderly individuals over eighty-five years of age?
"Participants must be between 12 and 50 years of age to qualify for this clinical trial."
Could I be a viable participant in this experiment?
"This trial is searching for 400 volunteers between the ages of 12 and 50 who are currently living with monkeypox. Qualified patients must meet these criteria in order to participate."
Are there any available vacancies in this trial for participants?
"As indicated on clinicaltrials.gov, this medical study is not presently accepting participants. Initially posted in March 15th2023 and last updated February 13th 2023, the trial has yet to begin recruiting patients. However there are 12 other trials that are actively seeking enrolment at the present moment."
How many medical sites are currently administering this research trial within the state?
"A number of medical centres are taking part in this trial, including The George Washington University Medical Faculty Associates - Infectious Diseases located in the District Of Columbia and National Institutes of Health's Clinical Centre as well as their Laboratory Of Immunoregulation. In addition, Brigham and Women's Hospital is accepting participants for this clinical research study. Altogether there are 13 sites recruiting patients."
What potential risks and side effects are associated with the use of 5?
"A score of 2 was attributed to the safety profile of compound 5, as it is presently being tested in a Phase 2 clinical trial. That said, there does exist data that supports its security but no evidence yet for its efficacy."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger